Sundar Ganapathy

Sundar helps life sciences leaders move AI from pilot into P&L. At Growth & Co, he partners with pharma, biotech, healthcare, and diagnostics executives to design, build, and scale agentic solutions across commercial and medical organizations — the operating models, governance, compliant workflows, and change architecture that make them work in regulated environments.

He spent eight years at McKinsey, where he led the firm's digital growth practice in life sciences. He advised Eli Lilly on the strategy, business plan, and product design behind LillyDirect, and led comparable work for Quest Diagnostics on Quest Health, its direct-to-consumer testing business. He has run sales, marketing, and medical affairs transformations anchored in AI enablement and operating-model redesign across pharma, diagnostics, and animal health.

Earlier in his career he built growth strategies in telecom, banking, retail, and media — industries that reached digital maturity a decade ahead of life sciences, and whose playbooks he now adapts to regulated environments. He does not stop at the roadmap: he aligns stakeholders, pressure-tests assumptions, and stands up the build teams, working alongside client engineers through deployment and adoption.